Investment Rating - The report assigns a "Buy" rating for the company, indicating a positive outlook for the stock price over the next six months [4]. Core Insights - The company has demonstrated significant revenue growth, achieving an operating income of 450 million yuan in H1 2025, representing a year-on-year increase of 25.6% [1]. - The gross profit margin improved to 37.6%, up by 3.6 percentage points, driven by a substantial reduction in expense ratios, particularly in sales and management costs [1]. - The adjusted net profit reached 39 million yuan, with an adjusted net profit margin of 8.63%, reflecting a notable improvement in profitability [1]. Summary by Sections Revenue Growth - In H1 2025, total revenue reached 460 million yuan, a 36.5% increase, with self-operated maternity centers contributing 387 million yuan, up 25.3% [2]. - The number of stores increased to 113, with a net addition of 36 stores compared to the end of 2024, indicating rapid expansion in the partnership store model [2]. - Customer recognition has improved, leading to an increase in average transaction values across different brands [2]. Business Segments - The home care business saw revenue growth of 41.7% in H1 2025, with a gross margin of 36.5% [3]. - The food business, focusing on women's health, generated revenue of 243,000 yuan, up 10.5%, with a gross margin of 72.4% [3]. - The introduction of new products has expanded the product matrix, enhancing the company's market position [3]. Financial Projections - Revenue forecasts for 2025-2027 are projected at 1.066 billion, 1.337 billion, and 1.640 billion yuan, respectively, with net profits expected to reach 120 million, 256 million, and 326 million yuan [4]. - The report anticipates continued improvement in operational and profitability metrics, supported by the rapid expansion of partnership stores and differentiated positioning [4].
圣贝拉（02508）：受托管理高速扩张，业务协同打造“月子生态”